Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) 27.9% HIGHER; announced the publication of an article that reviews and discusses the company’s seliciclib (CYC202 or R-roscovitine) product candidate, an orally available inhibitor of multiple cyclin-dependent kinases and its mechanism of action. The peer-reviewed article, “Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs” was published in the online edition of Current Drug Targets.

Magal Security Systems (Nasdaq: MAGS) 22.2% HIGHER; the stock seems to be breaking out on technicals today. Magal has been in the news recently given the recent attempted terrorist attack.

Luna Innovations (Nasdaq: LUNA) 19.1 HIGHER; the company announced yesterday